Wells Fargo
FBT icon

Wells Fargo’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Wells Fargo’s Portfolio FBT Stock Details FBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-600
Closed -$79K – 7538
2022
Q3 		$79K Buy
+600
New +$84.2K ﹤0.01% 4733

Other funds holding FBT

First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
BFG
Berger Financial Group Plymouth, Minnesota $1.79B AUM 15.72% 1-Year Est. Return
NP
Nilsine Partners Greenwood Village, Colorado $1.28B AUM 27.63% 1-Year Est. Return

Wells Fargo's FBT Position: Q1 2026 in Review

Wells Fargo increased its First Trust NYSE Arca Biotechnology Index Fund (FBT) stake by 126% in Q1 2026, buying an estimated $49.2M and bringing the position to 426,213 shares worth $85.6M. The position accounts for 0.02% of the portfolio, ranked #698.

Wells Fargo first reported a position in FBT in Q2 2013 and has held it in 52 quarters since. The position peaked at $254M in Q1 2015. 307 funds tracked by Wall St. Rank hold FBT as of Q1 2026.

  • Wells Fargo held 426,213 shares of First Trust NYSE Arca Biotechnology Index Fund worth $85.6M as of Q1 2026.
  • Wells Fargo bought 237,629 First Trust NYSE Arca Biotechnology Index Fund shares in Q1 2026, an estimated $49.2M.
  • First Trust NYSE Arca Biotechnology Index Fund made up 0.02% of Wells Fargo's portfolio in Q1 2026, its #698 holding.
  • Wells Fargo first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q2 2013 and has held it in 52 quarters since.
  • Wells Fargo's First Trust NYSE Arca Biotechnology Index Fund position peaked at $254M in Q1 2015.
  • 307 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q1 2026.

Based on Wells Fargo's 13F filing for Q1 2026, filed 11 May 2026.